Sofinnova Partners
About Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London, and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical, and business expertise.
Recent News
Healthtech, Biotech: Why the UK Is Emerging as an Essential Hub
Tenpoint Wins FDA Nod for Combination Presbyopia Eye Drop
Seven Italian Biotechs to Know About in 2026
Signadori Bio Raises €11M to Advance Tumour Platform
Excelsior Sciences Raises $95M in Funding
Latent Labs Launches Latent-X2 AI Drug Design Model
CellCentric Secures $220M in Europe’s Biggest Private Biotech Fundraise of 2026
Recent Deals
Elevara Medicines Raises $70M Series A to Advance RA and Inflammatory Disease Program
CellCentric Secures $220M Series D Funding to Advance Multiple Myeloma Drug
Excelsior Sciences Secures $95M Series A Funding Led by Deerfield, Khosla and Sofinnova
Neurent Medical Raises $74M in Series C Round to Commercialize Chronic Rhinitis Device
Mission Therapeutics Raises $13.3M From Existing Strategic Investors
Hemab Therapeutics Closes $157M Series C Led by Sofinnova Partners
Disco Pharmaceuticals Secures €36M Seed Funding
Hemab Therapeutics Raises $157M in Series C Led by Sofinnova Partners